Cargando…
Comparison of the Expression Changes after Botulinum Toxin Type A and Minocycline Administration in Lipopolysaccharide-Stimulated Rat Microglial and Astroglial Cultures
Botulinum neurotoxin type A (BoNT/A) and minocycline are potent drugs used in clinical therapies. The primary molecular mechanism of BoNT/A is the cleavage of SNARE proteins, which prevents cells from releasing neurotransmitters from vesicles, while the effects of minocycline are related to the inhi...
Autores principales: | Piotrowska, Anna, Popiolek-Barczyk, Katarzyna, Pavone, Flaminia, Mika, Joanna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5405066/ https://www.ncbi.nlm.nih.gov/pubmed/28491822 http://dx.doi.org/10.3389/fcimb.2017.00141 |
Ejemplares similares
-
Botulinum Toxin Type A—A Modulator of Spinal Neuron–Glia Interactions under Neuropathic Pain Conditions
por: Rojewska, Ewelina, et al.
Publicado: (2018) -
Biphalin, a Dimeric Enkephalin, Alleviates LPS-Induced Activation in Rat Primary Microglial Cultures in Opioid Receptor-Dependent and Receptor-Independent Manners
por: Popiolek-Barczyk, Katarzyna, et al.
Publicado: (2017) -
Targeting the Microglial Signaling Pathways: New Insights in the Modulation of Neuropathic Pain
por: Popiolek-Barczyk, Katarzyna, et al.
Publicado: (2016) -
Minocycline Enhances the Effectiveness of Nociceptin/Orphanin FQ during Neuropathic Pain
por: Popiolek-Barczyk, Katarzyna, et al.
Publicado: (2014) -
Targeting the NLRP3 Inflammasome-Related Pathways via Tianeptine Treatment-Suppressed Microglia Polarization to the M1 Phenotype in Lipopolysaccharide-Stimulated Cultures
por: Ślusarczyk, Joanna, et al.
Publicado: (2018)